Navigation Links
Progress Against Malaria: Developments on the Horizon

October 24, 2007
1 p.m. to 7:30 p.m.
The New York Academy of Sciences
7 World Trade Center
250 Greenwich Street, 40th Floor
New York, NY 10007

The Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health and The New York Academy of Sciences present Progress Against Malaria: Developments on the Horizon, a half-day symposium to highlight the latest research developments in the fight to combat malaria. This meeting will include discussions of new diagnostic tests, treatment and prevention strategies, and malaria-resistant mosquitoes. The symposium will also feature work from Macha, Zambia, where malaria research is conducted in a unique rural setting.

Online registration is available at To register by phone or to request accommodations for a disability, call 212-298-8615.

WEDNESDAY, OCTOBER 24, 2007 1:00 PM 5:30 PM

1:00 pm 2:00 pm Registration

2:00 pm 2:15 pm Welcome and Introduction
Ellis Rubinstein, President, The New York Academy of Sciences

2:15 pm 2:45 pm KEYNOTE LECTURE
Current Developments in Malaria Product Innovation and Control
Chris Hentschel, Ph.D., President and Chief Executive Officer, Medicines for Malaria Venture

2:45 pm 3:25 pm SESSION I: The State of the Art and Beyond:
Vaccine Development and Creation of Malaria-Resistant Mosquitoes

Mosquitoes That Cant Get Infected
Marcelo Jacobs-Lorena, Ph.D., Johns Hopkins Malaria Research Institute

Progress and Challenge in the Development of a Malaria Vaccine:
The PATH MVI Perspective
Christian Loucq, M.D., Director, The PATH Malaria Vaccine Initiative

3:25 pm 3:45 pm Coffee Break

3:45 pm 4:45 pm SESSION II: Progress in Diagnosis, Prevention and Treatment
Moderator: Diane Griffin, Ph.D., M.D., Johns Hopkins Bloomberg School of Public Health

Macha: A Living Laboratory in Rural Zambia
Douglas Norris, Ph.D., Johns Hopkins Malaria Research Institute

Using Human Saliva to Detect Malaria Infection
Sungano Mharakurwa, Ph.D., Johns Hopkins Malaria Research Institute

A Urine Dipstick for Malaria Diagnosis
David Sullivan, M.D., Johns Hopkins Malaria Research Institute

New Highly Active Artemisinin
Theresa Shapiro, M.D., Ph.D., Johns Hopkins Malaria Research Institute

Vaccination to Prevent Mosquito Infection
Nirbhay Kumar, Ph.D., Johns Hopkins Malaria Research Institute

4:45 pm 5:15 pm General Discussion and Questions

5:15 pm 5:30 pm Closing Remarks
Michael J. Klag, M.D., Dean, Johns Hopkins Bloomberg School of Public Health

5:30 pm 7:30 pm Reception


Contact: Tim Parsons
Johns Hopkins University Bloomberg School of Public Health

Related biology news :

1. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
2. Disease progression model of pancreatic cancer developed by Penn researchers
3. AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV
4. Progress on HIV/AIDS significant but insufficient
5. Cell therapy slows progression of an inherited neurological disease; Improves motor skills in mice
6. Genome changes tracked during multiple myeloma initiation, progression and treatment
7. Iraqs marshes show progress toward recovery
8. Progress being made in exploring potential use of stem cells to treat heart disease
9. Researchers make progress in studying genetic traits of India-born populations
10. Insulin receptor stops progression of Alzheimers disease
11. Progress made in HIV vaccine development
Post Your Comments:
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology: